| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/24/2003 | US20030140360 Transgenic mammals and reagents for improving long-term memory |
| 07/24/2003 | US20030139687 Noninvasive measurement of chemical substances |
| 07/24/2003 | US20030139590 Comprises nucleotide sequences coding orphan receptor 25 for detecting modulators of platelet activating factor (PAF) activity; antiinflammatory agents; gene/translation inhibition; drug screening |
| 07/24/2003 | US20030139584 Tumor necrosis factor Receptor-Associated Factor (TRAF) protein-interacting hereditary multiple extoses (TREX) for use in the diagnosis and treatment of cancer and autoimmune disorders; antitummor agents |
| 07/24/2003 | US20030139471 Compositions which contain triterpenes for regulating hair growth |
| 07/24/2003 | US20030139461 Antidiabetic formulation and method |
| 07/24/2003 | US20030139452 Pyrazole-derived kinase inhibitors and uses thereof |
| 07/24/2003 | US20030139447 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 07/24/2003 | US20030139443 Anxiolytic agents; veterinary medicine |
| 07/24/2003 | US20030139439 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 07/24/2003 | US20030139434 Combinations comprising dipeptidylpeptidase-iv inhibitor |
| 07/24/2003 | US20030139433 Incontinence |
| 07/24/2003 | US20030139422 Method for improving respiratory function and inhibiting muscular degeneration |
| 07/24/2003 | US20030139405 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 07/24/2003 | US20030139401 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
| 07/24/2003 | US20030139398 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders |
| 07/24/2003 | US20030139395 Synergistic mixture; psychological disorders, central nervous system disorders, cardiovascular disorders |
| 07/24/2003 | US20030139392 Herbal supplement for increased muscle strength and endurance for athletes |
| 07/24/2003 | US20030139386 Mixture with surfactants; cannabinol receptor; dietetics |
| 07/24/2003 | US20030139384 Transdermal supplying testosterone |
| 07/24/2003 | US20030139383 Respiratory system disorders |
| 07/24/2003 | US20030139381 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
| 07/24/2003 | US20030139378 Liquid bisphosphonate formulations for bone disorders |
| 07/24/2003 | US20030139372 Modulation of bone formation |
| 07/24/2003 | US20030139371 Drug for combating sexual dysfunctions |
| 07/24/2003 | US20030139370 Pharmaceutical agents containing acyclovir, fusaric acid and derivatives thereof |
| 07/24/2003 | US20030139368 Antithrombotic and/or anti-inflammatory composition combining purine activity and NSAID activity |
| 07/24/2003 | US20030139364 Methods and products for enhancing immune responses using imidazoquinoline compounds |
| 07/24/2003 | US20030139353 Using topoisomerase inhibitor; antiarthritic agents; respiratory system disorders; skin disorders |
| 07/24/2003 | US20030139352 Atp binding cassette drug transporter; antitumor agents; thgerapy for drug resistance |
| 07/24/2003 | US20030139350 Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 07/24/2003 | US20030139340 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (TFPI) |
| 07/24/2003 | US20030139339 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor ( TFPI) |
| 07/24/2003 | US20030139331 Treatment of cancer by reduction of intracellular energy and pyrimidines |
| 07/24/2003 | US20030139330 Transcription factors containing two potential dna binding motifs |
| 07/24/2003 | US20030138931 Hydrolase polypeptide for dephosphorylating mitogen activated kinases (MAP-kinase); antiapoptosis; antiproliferative agents |
| 07/24/2003 | US20030138884 APRIL- a novel protein with growth effects |
| 07/24/2003 | US20030138879 Phosphopantetheinyl transferases and uses thereof |
| 07/24/2003 | US20030138839 Polypeptide comprising ubiquitination regulating domain; antiproliferative agents; neuroprotectants; cancer diagnosis |
| 07/24/2003 | US20030138833 Psoriasin expression by breast epithelial cells |
| 07/24/2003 | US20030138832 Modulating insulin receptor signaling through targeting FACL |
| 07/24/2003 | US20030138820 Sugar transport protein for use in diagnosis and treatment of diabetes, hypertriglyceridemia and hyperinsulinemia |
| 07/24/2003 | US20030138815 Cyclic adenosine monophosphate (cAMP); drug screening; bronchodilators; antiinflammatory agents; immunomodulators; antiallergens; bioassays |
| 07/24/2003 | US20030138803 Identification and use of molecules implicated in pain |
| 07/24/2003 | US20030138793 Kit for identifying the origin of tumors in prostate, breast, colorectal, lung, ovarian, gastroesophageal, pancreatic, liver, kidney or bladder cells by way of probes for analyzing marker gene expression |
| 07/24/2003 | US20030138548 Weight management system for obese animals |
| 07/24/2003 | US20030138547 Pet food includes 35-70% by weight protein, 4-10% by weight fat, 5-25% by weight fiber, 10-35% by weight digestible carbohydrate, 0.1-1% by weight functional ingredient to build lean muscle mass |
| 07/24/2003 | US20030138543 Food product supplemented with proteoglycan precursors |
| 07/24/2003 | US20030138504 Cold compounded that promotes synthesis of nerve growth factor, an aldose reductase inhibitor and an antioxidant |
| 07/24/2003 | US20030138503 Topical pharmaceutical formulations and methods of treatment |
| 07/24/2003 | US20030138502 Method for protecting human skin |
| 07/24/2003 | US20030138499 Stable surgical irrigating solutions |
| 07/24/2003 | US20030138493 Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same |
| 07/24/2003 | US20030138458 HCV E1E2 vaccine compositions |
| 07/24/2003 | US20030138453 Microparticles comprise a polymer such as a poly(alpha-hydroxy acid), polyhydroxy butyric acid, polycaprolactone, a polyorthoester, a polyanhydride, formed using cationic, anionic, or nomonic detergents; drug delivery |
| 07/24/2003 | US20030138429 Compositions and methods for inhibiting metastasis |
| 07/24/2003 | US20030138423 Antiinflammation agents and immunotherapy using an enzyme inhibitor; sepsis; antiarthritic and - ulcer agents; colitis; myocarditis; glomerulonephritis; gastrointestinal and nervous system disorders; Crohn's disease; automimmune |
| 07/24/2003 | US20030138421 Human Antibodies specific for interleukin 15 (IL-15) |
| 07/24/2003 | US20030138416 Use of glucokinase activator in combination with a glucagon antagonist for treating type 2 diabetes |
| 07/24/2003 | US20030138414 Modulators of methylation for control of bacterial virulence |
| 07/24/2003 | US20030138413 Activating dendritic cells from the host which are rendered hyporesponsive to activation stimuli by the disease by administering a tumor-derived DC inhibitory factor antagonist in combination with a Toll-like receptor agonist |
| 07/24/2003 | US20030138399 Anti-inflammatory therapy for inflammatory mediated infection |
| 07/24/2003 | US20030138396 Administering a lipase inhibitor and a pharmaceutically acceptable bile acid sequestrant; anticholesterol agents |
| 07/24/2003 | US20030138390 Aging resistance |
| 07/24/2003 | US20030137304 E-water machine |
| 07/24/2003 | US20030136698 Medicinal product package for eradication therapy |
| 07/24/2003 | CA2651604A1 Method for preparation of substantially amorphous telmisartan |
| 07/24/2003 | CA2477348A1 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling |
| 07/24/2003 | CA2474151A1 Androgen regulated nucleic acid molecules and encoded proteins |
| 07/24/2003 | CA2473893A1 Stable salts of o-acetylsalicylic acid with basic amino acids ii |
| 07/24/2003 | CA2473570A1 Antisense compounds directed against human csf-1 |
| 07/24/2003 | CA2473039A1 Novel anti-igf-ir antibodies and uses thereof |
| 07/24/2003 | CA2472472A1 Treatment of bone disorders with skeletal anabolic drugs |
| 07/24/2003 | CA2472459A1 Use of cox-2 inhibitors in combination with antiviral agents for the treatment of papilloma virus infections |
| 07/24/2003 | CA2472199A1 Treatment involving peroxisome proliferator-activated receptor-gamma agonist and cyclooxygenase-2 selective inhibitors |
| 07/24/2003 | CA2472168A1 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
| 07/24/2003 | CA2472160A1 Quinazolinone compounds in combined modalities for improved cancer treatment |
| 07/24/2003 | CA2472016A1 Method and device for identifying substances capable of modulating adipicyte differentiation |
| 07/24/2003 | CA2471744A1 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs3 upregulation |
| 07/24/2003 | CA2471562A1 Tyrosyl derivatives and their use as p2x7 receptor modulators |
| 07/24/2003 | CA2471513A1 Macrophage migration inhibitory factor (mif) promoter polymorphism in inflammatory disease |
| 07/24/2003 | CA2471483A1 Polytartrate composition |
| 07/24/2003 | CA2471314A1 Anti-angiogenesis combination therapies comprising pyridazine or pyridine derivatives |
| 07/24/2003 | CA2470970A1 Post-conditioning for the reduction of ischemic-reperfusion injury in the heart and other organs |
| 07/24/2003 | CA2470430A1 Compositions comprising collagen and metalloprotease inhibitors |
| 07/24/2003 | CA2470359A1 Assay for the detection of factors that modulate the expression of ingap |
| 07/24/2003 | CA2464131A1 Compositions and methods for controlled release |
| 07/23/2003 | EP1329222A1 Isoflavone compositions for use in medicine |
| 07/23/2003 | EP1329220A1 Cytokine related treatments of disease |
| 07/23/2003 | EP1329218A1 Preventives/remedies for portal hypertension |
| 07/23/2003 | EP1328816A2 Regulation of neutral development by daedalos |
| 07/23/2003 | EP1328807A2 Use of vanilloid 4 receptor and antagonists or agonists thereof for treating diseases associated with pain |
| 07/23/2003 | EP1328646A2 Regulation of human adenylate cyclase, type iv |
| 07/23/2003 | EP1328635A2 Compositions and methods relating to lung specific genes |
| 07/23/2003 | EP1328630A2 Secreted proteins |
| 07/23/2003 | EP1328629A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 07/23/2003 | EP1328625A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 07/23/2003 | EP1328624A2 B7-like molecules and uses thereof |
| 07/23/2003 | EP1328550A2 Methods of selecting compounds for modulation of bladder function |
| 07/23/2003 | EP1328548A2 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |